Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Community testing via independent labs like Janoshik carries significant weight in these communities
TIER 1 (34mg total) $299 total for 8-10 week supply Monthly cost breakdown: $119-$149 based on weekly dose Recommended if new to treatment or for those on 2-4mg/week TIER 2 (68mg total) $339 total for 8-10 week supply Monthly cost breakdown: $135-$169 based on weekly dose Recommended for those on 5-8mg/week TIER 3 (102mg total) $369 total for 8-10 week supply Monthly cost breakdown: $147-$184 based on weekly dose Recommended for those on 9-12mg/week TIER 4 (136mg total) $399 total for 10 week supply Monthly cost breakdown: $159 based on weekly dose Recommended for those on 13mg/week and up EXTENDED PLANS Foundation Plan (85mg total) $425 total for 3-4+ supply Monthly cost breakdown: $106-141 based on weekly dose Recommended if new to treatment or for those on doses up to 7mg/week Momentum Plan (153mg total) $500 total for 3-4+ supply Monthly cost breakdown: $125 $167 based on weekly dose Recommended for doses up to 10mg/week Elevate Plan (204mg total) $550 for 3-4+ month supply Monthly cost breakdown: $137 $183 based on weekly dose Recommended for doses of 11mg/week & up MONTHLY PLANS Monthly Starter Dose $190 total for one month supply Recommended if new to treatment or for those on doses of 4mg/week or less Monthly Mid Dose $205 total for one month supply Recommended for doses up to 8.5mg/week Monthly Advanced Dose $225 total for one month supply Recommended for doses of 9-12.5mg/week Monthly Advanced Plus Dose $240 total for one month supply Recommended for doses of 13mg/week and up Southend Pharmacy - Tirzepatide/B6 Injection Up to 90 days BUD
It also may help lower HgbA1C levels
After a median follow-up of 104 weeks, treatment with tirzepatide was associated with a significant reduction in the risk of adjudicated death from cardiovascular causes or a worsening heart failure event (hazard ratio (HR) = 0.62
GLP-1 receptor agonist (RA) medications are highly effective for managing weight and blood sugar, but they can also disrupt digestive healthleading to discomfort, irregularity, and microbial imbalance
Lixisenatide: ELIXA 26,38 This trial was different from the remainder of the CVOTs discussed in this review in that only ELIXA enrolled people with a recent acute coronary syndrome
